dr. reddy's labs glp-1 receptor agonist title Today we launch, Obeda®, India's first DCGI-approved generic semaglutide injection for Type 2 Diabetes. This product reinforces our purpose of good health cant wait, to bring high quality and affordable treatment With the launch of Obeda®,
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 10 - Aug 15

























